

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of fibrinolysis (GO:0051918) | 7.93191990 |
| 2 | regulation of fibrinolysis (GO:0051917) | 7.57128963 |
| 3 | very-low-density lipoprotein particle assembly (GO:0034379) | 6.66031293 |
| 4 | protein carboxylation (GO:0018214) | 6.54297607 |
| 5 | peptidyl-glutamic acid carboxylation (GO:0017187) | 6.54297607 |
| 6 | L-phenylalanine catabolic process (GO:0006559) | 6.44574322 |
| 7 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.44574322 |
| 8 | regulation of protein activation cascade (GO:2000257) | 6.40750700 |
| 9 | plasma lipoprotein particle assembly (GO:0034377) | 6.27213331 |
| 10 | cholesterol efflux (GO:0033344) | 6.13120286 |
| 11 | regulation of complement activation (GO:0030449) | 6.09308951 |
| 12 | L-phenylalanine metabolic process (GO:0006558) | 6.06656844 |
| 13 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.06656844 |
| 14 | intestinal cholesterol absorption (GO:0030299) | 5.77924419 |
| 15 | negative regulation of cholesterol transport (GO:0032375) | 5.76509462 |
| 16 | negative regulation of sterol transport (GO:0032372) | 5.76509462 |
| 17 | regulation of cholesterol esterification (GO:0010872) | 5.67932853 |
| 18 | high-density lipoprotein particle remodeling (GO:0034375) | 5.56309233 |
| 19 | macromolecular complex remodeling (GO:0034367) | 5.54598625 |
| 20 | plasma lipoprotein particle remodeling (GO:0034369) | 5.54598625 |
| 21 | protein-lipid complex remodeling (GO:0034368) | 5.54598625 |
| 22 | blood coagulation, intrinsic pathway (GO:0007597) | 5.49834365 |
| 23 | protein-lipid complex assembly (GO:0065005) | 5.47088008 |
| 24 | complement activation, alternative pathway (GO:0006957) | 5.31284789 |
| 25 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.30669245 |
| 26 | exogenous drug catabolic process (GO:0042738) | 5.25820737 |
| 27 | phospholipid efflux (GO:0033700) | 5.11527440 |
| 28 | epoxygenase P450 pathway (GO:0019373) | 5.04401662 |
| 29 | fibrinolysis (GO:0042730) | 5.01557416 |
| 30 | reverse cholesterol transport (GO:0043691) | 5.00720482 |
| 31 | regulation of plasminogen activation (GO:0010755) | 4.91451862 |
| 32 | drug catabolic process (GO:0042737) | 4.89339566 |
| 33 | plasma lipoprotein particle organization (GO:0071827) | 4.87781951 |
| 34 | low-density lipoprotein particle remodeling (GO:0034374) | 4.77243192 |
| 35 | negative regulation of lipase activity (GO:0060192) | 4.71238605 |
| 36 | plasma lipoprotein particle clearance (GO:0034381) | 4.53859964 |
| 37 | protein-lipid complex subunit organization (GO:0071825) | 4.52527616 |
| 38 | glyoxylate metabolic process (GO:0046487) | 4.52266790 |
| 39 | cellular glucuronidation (GO:0052695) | 4.37587261 |
| 40 | ethanol oxidation (GO:0006069) | 4.34102509 |
| 41 | triglyceride homeostasis (GO:0070328) | 4.29046443 |
| 42 | acylglycerol homeostasis (GO:0055090) | 4.29046443 |
| 43 | aromatic amino acid family catabolic process (GO:0009074) | 4.23601184 |
| 44 | negative regulation of hemostasis (GO:1900047) | 4.21885592 |
| 45 | negative regulation of blood coagulation (GO:0030195) | 4.21885592 |
| 46 | positive regulation of triglyceride lipase activity (GO:0061365) | 4.20599753 |
| 47 | positive regulation of lipoprotein lipase activity (GO:0051006) | 4.20599753 |
| 48 | intestinal absorption (GO:0050892) | 4.19270562 |
| 49 | regulation of triglyceride catabolic process (GO:0010896) | 4.16769940 |
| 50 | regulation of bile acid biosynthetic process (GO:0070857) | 4.16142435 |
| 51 | omega-hydroxylase P450 pathway (GO:0097267) | 4.13105229 |
| 52 | regulation of apoptotic cell clearance (GO:2000425) | 4.12585379 |
| 53 | uronic acid metabolic process (GO:0006063) | 4.11588891 |
| 54 | glucuronate metabolic process (GO:0019585) | 4.11588891 |
| 55 | urea metabolic process (GO:0019627) | 4.10859486 |
| 56 | bile acid metabolic process (GO:0008206) | 4.08756740 |
| 57 | negative regulation of digestive system process (GO:0060457) | 4.07863217 |
| 58 | regulation of humoral immune response (GO:0002920) | 4.06845801 |
| 59 | regulation of DNA methylation (GO:0044030) | 3.99833794 |
| 60 | regulation of female gonad development (GO:2000194) | 3.97416945 |
| 61 | cholesterol homeostasis (GO:0042632) | 3.92360707 |
| 62 | sterol homeostasis (GO:0055092) | 3.87027788 |
| 63 | sterol transport (GO:0015918) | 3.81759972 |
| 64 | cholesterol transport (GO:0030301) | 3.81759972 |
| 65 | negative regulation of coagulation (GO:0050819) | 3.81566143 |
| 66 | protein activation cascade (GO:0072376) | 3.78879008 |
| 67 | negative regulation of protein activation cascade (GO:2000258) | 3.77728182 |
| 68 | regulation of acrosome reaction (GO:0060046) | 3.77664579 |
| 69 | positive regulation of blood coagulation (GO:0030194) | 3.74804007 |
| 70 | positive regulation of hemostasis (GO:1900048) | 3.74804007 |
| 71 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.74570300 |
| 72 | oxidative demethylation (GO:0070989) | 3.73941911 |
| 73 | nitrogen cycle metabolic process (GO:0071941) | 3.65724813 |
| 74 | imidazole-containing compound metabolic process (GO:0052803) | 3.65639463 |
| 75 | serine family amino acid catabolic process (GO:0009071) | 3.65464187 |
| 76 | negative regulation of wound healing (GO:0061045) | 3.63458852 |
| 77 | urea cycle (GO:0000050) | 3.62392772 |
| 78 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.57802428 |
| 79 | drug metabolic process (GO:0017144) | 3.55600385 |
| 80 | glutamate metabolic process (GO:0006536) | 3.54241090 |
| 81 | lipoprotein metabolic process (GO:0042157) | 3.51023672 |
| 82 | positive regulation of coagulation (GO:0050820) | 3.48587098 |
| 83 | drinking behavior (GO:0042756) | 3.48471187 |
| 84 | positive regulation of steroid metabolic process (GO:0045940) | 3.48350483 |
| 85 | acute-phase response (GO:0006953) | 3.47564226 |
| 86 | ethanol metabolic process (GO:0006067) | 3.45558395 |
| 87 | bile acid biosynthetic process (GO:0006699) | 3.44452144 |
| 88 | positive regulation of cellular amine metabolic process (GO:0033240) | 3.42716599 |
| 89 | drug transmembrane transport (GO:0006855) | 3.36850570 |
| 90 | regulation of lipoprotein particle clearance (GO:0010984) | 3.36138145 |
| 91 | regulation of cholesterol homeostasis (GO:2000188) | 3.35154130 |
| 92 | complement activation, classical pathway (GO:0006958) | 3.34726903 |
| 93 | glycine metabolic process (GO:0006544) | 3.34464456 |
| 94 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.30775170 |
| 95 | tyrosine metabolic process (GO:0006570) | 3.30303740 |
| 96 | bile acid and bile salt transport (GO:0015721) | 3.25495647 |
| 97 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 3.23974125 |
| 98 | piRNA metabolic process (GO:0034587) | 3.16825232 |
| 99 | lipid homeostasis (GO:0055088) | 3.14032381 |
| 100 | regulation of meiosis I (GO:0060631) | 3.10548545 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 9.57712258 |
| 2 | EZH2_22144423_ChIP-Seq_EOC_Human | 6.47589236 |
| 3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.26273082 |
| 4 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.66228870 |
| 5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.60395828 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.12511680 |
| 7 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 4.09639846 |
| 8 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.01564421 |
| 9 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 3.64224743 |
| 10 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.49023392 |
| 11 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 3.35397692 |
| 12 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 3.31727141 |
| 13 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.22407802 |
| 14 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 2.94143012 |
| 15 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 2.92281619 |
| 16 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.85304210 |
| 17 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.84853472 |
| 18 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.84499491 |
| 19 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.67973298 |
| 20 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.33879045 |
| 21 | AR_21909140_ChIP-Seq_LNCAP_Human | 2.26295870 |
| 22 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.87950967 |
| 23 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.86870320 |
| 24 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.78336634 |
| 25 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.78336634 |
| 26 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.78336634 |
| 27 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.69209484 |
| 28 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.62686873 |
| 29 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.56345326 |
| 30 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.53193820 |
| 31 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.48030547 |
| 32 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.37814582 |
| 33 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.36649913 |
| 34 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.36140556 |
| 35 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.30728336 |
| 36 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 1.25811948 |
| 37 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.17850006 |
| 38 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.17042193 |
| 39 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.13643728 |
| 40 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.08208989 |
| 41 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.05609821 |
| 42 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.02958350 |
| 43 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.02922258 |
| 44 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.00255406 |
| 45 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.98883524 |
| 46 | CBP_21632823_ChIP-Seq_H3396_Human | 0.97566776 |
| 47 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 0.97117394 |
| 48 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.93491504 |
| 49 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.92903152 |
| 50 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.92216897 |
| 51 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.92121914 |
| 52 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.90484657 |
| 53 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.90412951 |
| 54 | TP53_16413492_ChIP-PET_HCT116_Human | 0.88338911 |
| 55 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.87616005 |
| 56 | AR_20517297_ChIP-Seq_VCAP_Human | 0.86728846 |
| 57 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.85195260 |
| 58 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.84951301 |
| 59 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.82369772 |
| 60 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.81510511 |
| 61 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.81493209 |
| 62 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.80230386 |
| 63 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.79722354 |
| 64 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.78941859 |
| 65 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.78460663 |
| 66 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.77248003 |
| 67 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.75710655 |
| 68 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.74870731 |
| 69 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.73379113 |
| 70 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.72301860 |
| 71 | TCF4_23295773_ChIP-Seq_U87_Human | 0.71876680 |
| 72 | GF1_26923725_Chip-Seq_HPCs_Mouse | 0.71754843 |
| 73 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.70280494 |
| 74 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.70133240 |
| 75 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.69762897 |
| 76 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.68068802 |
| 77 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.67879770 |
| 78 | STAT3_23295773_ChIP-Seq_U87_Human | 0.67344674 |
| 79 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.66736239 |
| 80 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.66736239 |
| 81 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.64979451 |
| 82 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.64181288 |
| 83 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.60430441 |
| 84 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.60191913 |
| 85 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.60058802 |
| 86 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.59413497 |
| 87 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.59289138 |
| 88 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.59165425 |
| 89 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.58856291 |
| 90 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.56823934 |
| 91 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.56683129 |
| 92 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.56683129 |
| 93 | AR_25329375_ChIP-Seq_VCAP_Human | 0.56366511 |
| 94 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.56357318 |
| 95 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.54049367 |
| 96 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.54049367 |
| 97 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.52134897 |
| 98 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.52054259 |
| 99 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.51522025 |
| 100 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.50974326 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.45241083 |
| 2 | MP0005360_urolithiasis | 6.59784033 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 4.87094790 |
| 4 | MP0005365_abnormal_bile_salt | 4.77024085 |
| 5 | MP0003195_calcinosis | 4.66965567 |
| 6 | MP0003718_maternal_effect | 4.08411168 |
| 7 | MP0001666_abnormal_nutrient_absorption | 3.89575295 |
| 8 | MP0008875_abnormal_xenobiotic_pharmacok | 3.61547110 |
| 9 | MP0009840_abnormal_foam_cell | 3.39826639 |
| 10 | MP0003252_abnormal_bile_duct | 3.36763375 |
| 11 | MP0010329_abnormal_lipoprotein_level | 3.13048068 |
| 12 | MP0002138_abnormal_hepatobiliary_system | 2.86607937 |
| 13 | MP0003868_abnormal_feces_composition | 2.66814539 |
| 14 | MP0006292_abnormal_olfactory_placode | 2.45086325 |
| 15 | MP0000566_synostosis | 2.38070206 |
| 16 | MP0003122_maternal_imprinting | 2.26092162 |
| 17 | MP0005395_other_phenotype | 1.97812044 |
| 18 | MP0003879_abnormal_hair_cell | 1.80943464 |
| 19 | MP0003890_abnormal_embryonic-extraembry | 1.80700828 |
| 20 | MP0005332_abnormal_amino_acid | 1.76342048 |
| 21 | MP0010368_abnormal_lymphatic_system | 1.73670643 |
| 22 | MP0002118_abnormal_lipid_homeostasis | 1.54689208 |
| 23 | MP0005408_hypopigmentation | 1.49434348 |
| 24 | MP0003183_abnormal_peptide_metabolism | 1.49139713 |
| 25 | MP0008789_abnormal_olfactory_epithelium | 1.47525131 |
| 26 | MP0004019_abnormal_vitamin_homeostasis | 1.42888575 |
| 27 | MP0005499_abnormal_olfactory_system | 1.40961281 |
| 28 | MP0005394_taste/olfaction_phenotype | 1.40961281 |
| 29 | MP0000609_abnormal_liver_physiology | 1.32310950 |
| 30 | MP0003699_abnormal_female_reproductive | 1.27487823 |
| 31 | MP0003950_abnormal_plasma_membrane | 1.24846006 |
| 32 | MP0009697_abnormal_copulation | 1.20970922 |
| 33 | MP0002876_abnormal_thyroid_physiology | 1.16398026 |
| 34 | MP0002132_abnormal_respiratory_system | 1.15060171 |
| 35 | MP0005410_abnormal_fertilization | 1.14935413 |
| 36 | MP0002089_abnormal_postnatal_growth/wei | 1.10296725 |
| 37 | MP0001764_abnormal_homeostasis | 1.07684431 |
| 38 | MP0003121_genomic_imprinting | 1.06470120 |
| 39 | MP0003191_abnormal_cellular_cholesterol | 1.04092036 |
| 40 | MP0005319_abnormal_enzyme/_coenzyme | 1.02084797 |
| 41 | MP0005646_abnormal_pituitary_gland | 0.99848335 |
| 42 | MP0010030_abnormal_orbit_morphology | 0.97183412 |
| 43 | MP0001929_abnormal_gametogenesis | 0.94246652 |
| 44 | MP0002160_abnormal_reproductive_system | 0.92899583 |
| 45 | MP0008877_abnormal_DNA_methylation | 0.91482298 |
| 46 | MP0010234_abnormal_vibrissa_follicle | 0.90742376 |
| 47 | MP0002234_abnormal_pharynx_morphology | 0.88306748 |
| 48 | MP0001293_anophthalmia | 0.86581265 |
| 49 | MP0005451_abnormal_body_composition | 0.84511460 |
| 50 | MP0001915_intracranial_hemorrhage | 0.84301396 |
| 51 | MP0002161_abnormal_fertility/fecundity | 0.82912024 |
| 52 | MP0005647_abnormal_sex_gland | 0.78865161 |
| 53 | MP0005058_abnormal_lysosome_morphology | 0.78750144 |
| 54 | MP0005409_darkened_coat_color | 0.74990904 |
| 55 | MP0005636_abnormal_mineral_homeostasis | 0.73240296 |
| 56 | MP0000653_abnormal_sex_gland | 0.73075337 |
| 57 | MP0000598_abnormal_liver_morphology | 0.71265146 |
| 58 | MP0003123_paternal_imprinting | 0.71114288 |
| 59 | MP0009780_abnormal_chondrocyte_physiolo | 0.70096248 |
| 60 | MP0009642_abnormal_blood_homeostasis | 0.70039250 |
| 61 | MP0003136_yellow_coat_color | 0.69627604 |
| 62 | MP0001324_abnormal_eye_pigmentation | 0.69431642 |
| 63 | MP0002210_abnormal_sex_determination | 0.69054352 |
| 64 | MP0003656_abnormal_erythrocyte_physiolo | 0.68264092 |
| 65 | MP0003806_abnormal_nucleotide_metabolis | 0.67436366 |
| 66 | MP0002233_abnormal_nose_morphology | 0.67164113 |
| 67 | MP0009643_abnormal_urine_homeostasis | 0.63668989 |
| 68 | MP0005551_abnormal_eye_electrophysiolog | 0.62458025 |
| 69 | MP0003693_abnormal_embryo_hatching | 0.61977126 |
| 70 | MP0004043_abnormal_pH_regulation | 0.58769244 |
| 71 | MP0004142_abnormal_muscle_tone | 0.54480662 |
| 72 | MP0000639_abnormal_adrenal_gland | 0.54157416 |
| 73 | MP0001730_embryonic_growth_arrest | 0.52868211 |
| 74 | MP0001756_abnormal_urination | 0.51492192 |
| 75 | MP0001119_abnormal_female_reproductive | 0.50954708 |
| 76 | MP0003698_abnormal_male_reproductive | 0.50942095 |
| 77 | MP0002078_abnormal_glucose_homeostasis | 0.49992481 |
| 78 | MP0001986_abnormal_taste_sensitivity | 0.49744025 |
| 79 | MP0003953_abnormal_hormone_level | 0.49519828 |
| 80 | MP0001145_abnormal_male_reproductive | 0.49367778 |
| 81 | MP0003941_abnormal_skin_development | 0.49314989 |
| 82 | MP0000762_abnormal_tongue_morphology | 0.48669720 |
| 83 | MP0005376_homeostasis/metabolism_phenot | 0.47191156 |
| 84 | MP0003119_abnormal_digestive_system | 0.45614201 |
| 85 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.45421937 |
| 86 | MP0005389_reproductive_system_phenotype | 0.43503302 |
| 87 | MP0005084_abnormal_gallbladder_morpholo | 0.43397300 |
| 88 | MP0000678_abnormal_parathyroid_gland | 0.43094220 |
| 89 | MP0001984_abnormal_olfaction | 0.42750645 |
| 90 | MP0002971_abnormal_brown_adipose | 0.42280489 |
| 91 | MP0001661_extended_life_span | 0.41240366 |
| 92 | MP0005464_abnormal_platelet_physiology | 0.40588327 |
| 93 | MP0003567_abnormal_fetal_cardiomyocyte | 0.39116681 |
| 94 | MP0009115_abnormal_fat_cell | 0.38661038 |
| 95 | MP0002168_other_aberrant_phenotype | 0.38284271 |
| 96 | MP0002282_abnormal_trachea_morphology | 0.37636467 |
| 97 | MP0005334_abnormal_fat_pad | 0.37227826 |
| 98 | MP0005220_abnormal_exocrine_pancreas | 0.36745581 |
| 99 | MP0008469_abnormal_protein_level | 0.36675956 |
| 100 | MP0001944_abnormal_pancreas_morphology | 0.35879342 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 9.81483894 |
| 2 | Prolonged partial thromboplastin time (HP:0003645) | 7.99724551 |
| 3 | Hypobetalipoproteinemia (HP:0003563) | 7.05181076 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.86718962 |
| 5 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.83372902 |
| 6 | Complement deficiency (HP:0004431) | 6.23320688 |
| 7 | Joint hemorrhage (HP:0005261) | 5.88147908 |
| 8 | Abnormality of the common coagulation pathway (HP:0010990) | 4.85518765 |
| 9 | Abnormality of complement system (HP:0005339) | 4.65344893 |
| 10 | Hypolipoproteinemia (HP:0010981) | 4.49013739 |
| 11 | Intrahepatic cholestasis (HP:0001406) | 4.48452121 |
| 12 | Xanthomatosis (HP:0000991) | 4.42957072 |
| 13 | Spontaneous abortion (HP:0005268) | 4.34927946 |
| 14 | Hypophosphatemic rickets (HP:0004912) | 4.32144677 |
| 15 | Osteomalacia (HP:0002749) | 4.21124132 |
| 16 | Conjugated hyperbilirubinemia (HP:0002908) | 4.15098311 |
| 17 | Systemic lupus erythematosus (HP:0002725) | 4.06055844 |
| 18 | Glomerulonephritis (HP:0000099) | 4.05191474 |
| 19 | Hypercholesterolemia (HP:0003124) | 3.80482261 |
| 20 | Fat malabsorption (HP:0002630) | 3.67373526 |
| 21 | Hyperlipoproteinemia (HP:0010980) | 3.62795706 |
| 22 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.55757294 |
| 23 | Generalized aminoaciduria (HP:0002909) | 3.36670298 |
| 24 | Hyperglycinemia (HP:0002154) | 3.34974963 |
| 25 | Hemorrhage of the eye (HP:0011885) | 3.33989645 |
| 26 | Vascular calcification (HP:0004934) | 3.31143310 |
| 27 | Rickets (HP:0002748) | 3.25093471 |
| 28 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.19391093 |
| 29 | Cholecystitis (HP:0001082) | 3.12213408 |
| 30 | Abnormal gallbladder physiology (HP:0012438) | 3.12213408 |
| 31 | Supernumerary spleens (HP:0009799) | 3.05440254 |
| 32 | Hypoalphalipoproteinemia (HP:0003233) | 3.01785728 |
| 33 | Epidermoid cyst (HP:0200040) | 3.01329858 |
| 34 | Menorrhagia (HP:0000132) | 2.98283918 |
| 35 | Abnormal tarsal ossification (HP:0008369) | 2.90922884 |
| 36 | Acanthocytosis (HP:0001927) | 2.87783961 |
| 37 | Cardiovascular calcification (HP:0011915) | 2.83100654 |
| 38 | Hypoglycemic coma (HP:0001325) | 2.76176138 |
| 39 | Steatorrhea (HP:0002570) | 2.75261333 |
| 40 | Proximal tubulopathy (HP:0000114) | 2.73474445 |
| 41 | Abnormality of carpal bone ossification (HP:0006257) | 2.66332372 |
| 42 | Mitral stenosis (HP:0001718) | 2.60666598 |
| 43 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.57764268 |
| 44 | Abnormality of glycine metabolism (HP:0010895) | 2.57764268 |
| 45 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.57423321 |
| 46 | Abnormality of the intrinsic pathway (HP:0010989) | 2.57206499 |
| 47 | Gingival bleeding (HP:0000225) | 2.55400324 |
| 48 | Broad alveolar ridges (HP:0000187) | 2.42128565 |
| 49 | Impulsivity (HP:0100710) | 2.41974701 |
| 50 | Nephritis (HP:0000123) | 2.38257464 |
| 51 | Fair hair (HP:0002286) | 2.36224775 |
| 52 | Pigmentary retinal degeneration (HP:0001146) | 2.31717754 |
| 53 | Flat acetabular roof (HP:0003180) | 2.31596194 |
| 54 | Azoospermia (HP:0000027) | 2.29493633 |
| 55 | Malnutrition (HP:0004395) | 2.27982570 |
| 56 | Purpura (HP:0000979) | 2.27070215 |
| 57 | Facial hemangioma (HP:0000329) | 2.25452586 |
| 58 | Bifid scrotum (HP:0000048) | 2.24628132 |
| 59 | Glycosuria (HP:0003076) | 2.21549403 |
| 60 | Abnormality of urine glucose concentration (HP:0011016) | 2.21549403 |
| 61 | Papillary thyroid carcinoma (HP:0002895) | 2.21303984 |
| 62 | Hyperglycinuria (HP:0003108) | 2.20314365 |
| 63 | Metaphyseal irregularity (HP:0003025) | 2.17435327 |
| 64 | Thrombophlebitis (HP:0004418) | 2.15324552 |
| 65 | Abnormal urine phosphate concentration (HP:0012599) | 2.14792086 |
| 66 | Hyperammonemia (HP:0001987) | 2.13276107 |
| 67 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.12427297 |
| 68 | Prenatal maternal abnormality (HP:0002686) | 2.11113795 |
| 69 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.10047731 |
| 70 | Premature ovarian failure (HP:0008209) | 2.06931506 |
| 71 | Delayed CNS myelination (HP:0002188) | 2.06645961 |
| 72 | Abnormality of methionine metabolism (HP:0010901) | 2.04387881 |
| 73 | Hepatocellular carcinoma (HP:0001402) | 2.03970588 |
| 74 | Myocardial infarction (HP:0001658) | 2.01580147 |
| 75 | Abnormal hand bone ossification (HP:0010660) | 2.00666584 |
| 76 | Enlarged kidneys (HP:0000105) | 1.96465450 |
| 77 | Megaloblastic anemia (HP:0001889) | 1.93688975 |
| 78 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.93123216 |
| 79 | Hyperphosphaturia (HP:0003109) | 1.92451852 |
| 80 | Abnormality of vitamin metabolism (HP:0100508) | 1.90081139 |
| 81 | Poikilocytosis (HP:0004447) | 1.88743457 |
| 82 | Abnormality of proline metabolism (HP:0010907) | 1.83574102 |
| 83 | Hydroxyprolinuria (HP:0003080) | 1.83574102 |
| 84 | Lower limb hyperreflexia (HP:0002395) | 1.83097756 |
| 85 | Abnormal ossification of hand bones (HP:0005921) | 1.81593066 |
| 86 | Nausea (HP:0002018) | 1.77733901 |
| 87 | Abnormality of nucleobase metabolism (HP:0010932) | 1.76606282 |
| 88 | Elevated alkaline phosphatase (HP:0003155) | 1.75138304 |
| 89 | Potter facies (HP:0002009) | 1.75054125 |
| 90 | Facial shape deformation (HP:0011334) | 1.75054125 |
| 91 | Increased serum pyruvate (HP:0003542) | 1.73199809 |
| 92 | Striae distensae (HP:0001065) | 1.72740056 |
| 93 | Abnormal foot bone ossification (HP:0010675) | 1.72039000 |
| 94 | Retinal atrophy (HP:0001105) | 1.70413408 |
| 95 | Capillary hemangiomas (HP:0005306) | 1.70161438 |
| 96 | Male infertility (HP:0003251) | 1.68100823 |
| 97 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.67130194 |
| 98 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.65935631 |
| 99 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.62868614 |
| 100 | Hypophosphatemia (HP:0002148) | 1.60193512 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K9 | 5.44010472 |
| 2 | ARAF | 4.44142363 |
| 3 | MAP3K13 | 4.36887593 |
| 4 | FGFR4 | 4.08135211 |
| 5 | CDK12 | 3.26918105 |
| 6 | FGFR3 | 2.67960007 |
| 7 | STK24 | 2.44684061 |
| 8 | WNK4 | 2.29072615 |
| 9 | TAOK3 | 2.26103158 |
| 10 | NEK6 | 2.17850914 |
| 11 | KSR2 | 2.17607779 |
| 12 | LATS1 | 2.00646068 |
| 13 | ICK | 1.98061349 |
| 14 | TTK | 1.92188380 |
| 15 | MET | 1.86472408 |
| 16 | BRAF | 1.76216270 |
| 17 | CDK9 | 1.67752601 |
| 18 | CDK7 | 1.66108981 |
| 19 | NEK9 | 1.53511263 |
| 20 | PIK3CA | 1.52453434 |
| 21 | ERN1 | 1.52309572 |
| 22 | TYRO3 | 1.51565525 |
| 23 | MOS | 1.50586238 |
| 24 | EIF2AK3 | 1.45332954 |
| 25 | LATS2 | 1.38140551 |
| 26 | RAF1 | 1.35322221 |
| 27 | WNK1 | 1.35311857 |
| 28 | AURKA | 1.32178602 |
| 29 | MELK | 1.31432285 |
| 30 | MAPKAPK3 | 1.27330477 |
| 31 | PRKAA2 | 1.25287193 |
| 32 | NEK2 | 1.17076196 |
| 33 | NTRK3 | 1.14436183 |
| 34 | MAPK11 | 1.11965969 |
| 35 | BRSK2 | 1.07037271 |
| 36 | FGFR2 | 1.04260861 |
| 37 | RET | 1.03802224 |
| 38 | PDPK1 | 1.02799568 |
| 39 | FGFR1 | 1.00287173 |
| 40 | RIPK1 | 1.00048151 |
| 41 | NTRK2 | 0.99641623 |
| 42 | BRSK1 | 0.93275702 |
| 43 | ZAK | 0.91140111 |
| 44 | PLK1 | 0.86363807 |
| 45 | STK39 | 0.85505467 |
| 46 | STK3 | 0.85368763 |
| 47 | PRKCI | 0.82264753 |
| 48 | EPHA4 | 0.81292077 |
| 49 | PDK1 | 0.79771473 |
| 50 | NLK | 0.78975374 |
| 51 | CSNK1E | 0.78001135 |
| 52 | EEF2K | 0.76674676 |
| 53 | EIF2AK1 | 0.75660230 |
| 54 | CDK8 | 0.72440853 |
| 55 | PRKG1 | 0.71071040 |
| 56 | ACVR1B | 0.69781022 |
| 57 | DYRK1B | 0.66636644 |
| 58 | CSNK1D | 0.66450301 |
| 59 | STK38L | 0.64294298 |
| 60 | MAP3K5 | 0.63117477 |
| 61 | CDC7 | 0.63098115 |
| 62 | AKT3 | 0.61480224 |
| 63 | MAP3K1 | 0.59839276 |
| 64 | PRKCZ | 0.59526290 |
| 65 | PTK2 | 0.59464396 |
| 66 | PIK3CG | 0.59223616 |
| 67 | PRKACG | 0.59118527 |
| 68 | PKN2 | 0.56390459 |
| 69 | TNIK | 0.53514607 |
| 70 | PLK3 | 0.52555263 |
| 71 | TESK2 | 0.52370894 |
| 72 | MAP3K8 | 0.49504851 |
| 73 | PRKAA1 | 0.46599224 |
| 74 | MTOR | 0.46568952 |
| 75 | CDK2 | 0.46563698 |
| 76 | PDGFRA | 0.45964650 |
| 77 | ERBB2 | 0.44587720 |
| 78 | MAP3K2 | 0.44239030 |
| 79 | BCKDK | 0.43612695 |
| 80 | PRKACB | 0.40434660 |
| 81 | AURKB | 0.38837941 |
| 82 | RPS6KB1 | 0.38799865 |
| 83 | PRKACA | 0.37701807 |
| 84 | NME1 | 0.37580815 |
| 85 | TRIB3 | 0.37119652 |
| 86 | CHEK1 | 0.36971911 |
| 87 | CDK1 | 0.36411729 |
| 88 | CSNK2A2 | 0.35659177 |
| 89 | IGF1R | 0.35650664 |
| 90 | PIM1 | 0.35252225 |
| 91 | TGFBR2 | 0.35116335 |
| 92 | ATM | 0.33537988 |
| 93 | NUAK1 | 0.32669498 |
| 94 | MAP3K3 | 0.31758281 |
| 95 | AKT2 | 0.30850820 |
| 96 | PBK | 0.30488371 |
| 97 | CSNK2A1 | 0.30260354 |
| 98 | STK16 | 0.30253028 |
| 99 | CSNK1G1 | 0.28740628 |
| 100 | SGK1 | 0.27532117 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 4.31843825 |
| 2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.90808802 |
| 3 | Caffeine metabolism_Homo sapiens_hsa00232 | 3.79774359 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.22672736 |
| 5 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.00679131 |
| 6 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.76306191 |
| 7 | Retinol metabolism_Homo sapiens_hsa00830 | 2.67174965 |
| 8 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.57130573 |
| 9 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.53466298 |
| 10 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.46581817 |
| 11 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.43901800 |
| 12 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.30762066 |
| 13 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.30288539 |
| 14 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 2.19385752 |
| 15 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 2.17643622 |
| 16 | Histidine metabolism_Homo sapiens_hsa00340 | 2.12668943 |
| 17 | Fat digestion and absorption_Homo sapiens_hsa04975 | 2.12444150 |
| 18 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.08915088 |
| 19 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.01265122 |
| 20 | Bile secretion_Homo sapiens_hsa04976 | 2.00599892 |
| 21 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.93443106 |
| 22 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.86163091 |
| 23 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.80311359 |
| 24 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.78250951 |
| 25 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.64514671 |
| 26 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.58847638 |
| 27 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.57857534 |
| 28 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.51223766 |
| 29 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.46908006 |
| 30 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.44501584 |
| 31 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.38662130 |
| 32 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.38454628 |
| 33 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.34027143 |
| 34 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.33637784 |
| 35 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.32266276 |
| 36 | Peroxisome_Homo sapiens_hsa04146 | 1.29491904 |
| 37 | ABC transporters_Homo sapiens_hsa02010 | 1.29412311 |
| 38 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.27387871 |
| 39 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.24169693 |
| 40 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.20170929 |
| 41 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.19782678 |
| 42 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.12927191 |
| 43 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.10041308 |
| 44 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.06042150 |
| 45 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.05521312 |
| 46 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.05142454 |
| 47 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.00552087 |
| 48 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.97759723 |
| 49 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.88953839 |
| 50 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.87108896 |
| 51 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.87061214 |
| 52 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.83157968 |
| 53 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.83057335 |
| 54 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.78478683 |
| 55 | Basal transcription factors_Homo sapiens_hsa03022 | 0.76627991 |
| 56 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.73771085 |
| 57 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.70005668 |
| 58 | Carbon metabolism_Homo sapiens_hsa01200 | 0.68282687 |
| 59 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.64817574 |
| 60 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.63387392 |
| 61 | Prion diseases_Homo sapiens_hsa05020 | 0.61721140 |
| 62 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.57227089 |
| 63 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.56743567 |
| 64 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.55129367 |
| 65 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.54629257 |
| 66 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.52044054 |
| 67 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.51888267 |
| 68 | Lysine degradation_Homo sapiens_hsa00310 | 0.50872226 |
| 69 | Metabolic pathways_Homo sapiens_hsa01100 | 0.50358637 |
| 70 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.46651405 |
| 71 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.44241176 |
| 72 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.37202162 |
| 73 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.37039611 |
| 74 | Other glycan degradation_Homo sapiens_hsa00511 | 0.36158257 |
| 75 | Cell cycle_Homo sapiens_hsa04110 | 0.35212917 |
| 76 | Mineral absorption_Homo sapiens_hsa04978 | 0.33718957 |
| 77 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.31929155 |
| 78 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.26495937 |
| 79 | Circadian rhythm_Homo sapiens_hsa04710 | 0.26263483 |
| 80 | Sulfur relay system_Homo sapiens_hsa04122 | 0.23747600 |
| 81 | Insulin resistance_Homo sapiens_hsa04931 | 0.23644323 |
| 82 | Galactose metabolism_Homo sapiens_hsa00052 | 0.22885321 |
| 83 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.20208682 |
| 84 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.18074690 |
| 85 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.17595868 |
| 86 | Base excision repair_Homo sapiens_hsa03410 | 0.17107538 |
| 87 | Mismatch repair_Homo sapiens_hsa03430 | 0.15268757 |
| 88 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.08621876 |
| 89 | Pertussis_Homo sapiens_hsa05133 | 0.08142140 |
| 90 | RNA degradation_Homo sapiens_hsa03018 | 0.07951994 |
| 91 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.07758867 |
| 92 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.05934301 |
| 93 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.04254932 |
| 94 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.03892957 |
| 95 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.01613234 |
| 96 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.00730622 |
| 97 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.00706319 |
| 98 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.00227547 |
| 99 | Selenocompound metabolism_Homo sapiens_hsa00450 | -0.0062368 |
| 100 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | -0.0029152 |

